Myositis-specific antibodies (MSAs) are associated with certain symptoms in JM patients. In some cases, knowing the MSA of a patient may help clinicians look out for certain symptoms and guide treatment decisions. Dr. Jessica Neely explains these associations, why they are important, and the limitations in our understanding of the role of MSAs in JM.
Jessica Neely, MD, is a Pediatric Rheumatologist at the University of California, San Francisco. She diagnoses and treats children with all types of autoimmune diseases and is also a clinical and translational researcher. Dr. Neely is a member of Cure JM’s Clinical Care Network.
